<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01639664</url>
  </required_header>
  <id_info>
    <org_study_id>6233</org_study_id>
    <nct_id>NCT01639664</nct_id>
  </id_info>
  <brief_title>COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2</brief_title>
  <acronym>COMPACT-2</acronym>
  <official_title>COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of High Doses CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BELLCO Srl Mirandola (MO) ITALY</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to clarify whether the application of high doses CPFA (coupled
      plasma-filtration adsorption) in addition to the current clinical practice is able to reduce
      hospital mortality in septic shock patients in intensive care unit (ICU).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic shock is a life-threatening clinical condition characterized by cardiovascular failure
      as a consequence of infection. Septic shock frequently causes multi-organ failure in the ICU.
      For this reason the extracorporeal therapies for the treatment of renal failure have become
      widespread in the ICU and, at the same time, new extracorporeal depurative techniques have
      been developed for the removal of inflammatory mediators. One of these techniques is CPFA
      (coupled plasma-filtration adsorption) that uses a sorbent once the separation between plasma
      and blood has been obtained with a plasma filter. The study objective is to clarify whether
      the application of high doses CPFA in addition to the current clinical practice is able to
      reduce hospital mortality in septic shock patients in intensive care unit. Secondary
      objectives are the resolution of septic shock and the reduction of ICU LOS (length of stay).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>At the discharge from the latest hospital (on average 30,3 days)</time_frame>
    <description>For patients discharged to other hospital, it will be intended as mortality at the discharge from the latest hospital in which the patients stayed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality within 90 days from randomization</measure>
    <time_frame>90 days from randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU LOS reduction measured as days not spent in the ICU during the first 30 days from randomization</measure>
    <time_frame>30 days from randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Septic shock resolution measured as number of days free of vasoactive drugs from randomization</measure>
    <time_frame>15 days from randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Shock, Septic</condition>
  <arm_group>
    <arm_group_label>High doses CPFA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High doses CPFA (coupled plasma-filtration adsorption) with AMPLYA™ (BELLCO ITALY): &gt;0.20 L/kg/day of plasma treated in the first 3 days after randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High doses CPFA</intervention_name>
    <description>High doses CPFA (coupled plasma-filtration adsorption) with AMPLYA™ (BELLCO ITALY): &gt;0.20 L/kg/day of plasma treated in the first 3 days after randomization.</description>
    <arm_group_label>High doses CPFA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to the ICU in septic shock

          -  All patients that develop septic shock while in the ICU

        Exclusion Criteria:

          -  Age less than 14 years

          -  Pregnancy

          -  Estimated life expectancy (due to comorbidities) less than 90 days

          -  Presence of relative or absolute contraindications to CPFA

          -  Admission from an other ICU where the patient remained for more than 24 hours

          -  Absence of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio Livigni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Giovanni Bosco, Torino, ITALY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guido Bertolini, MD</last_name>
    <phone>+390354535313</phone>
    <email>guido.bertolini@marionegri.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luana Nava</last_name>
    <phone>+390354535313</phone>
    <email>luana.nava@marionegri.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale Madonna delle Grazie, U.O. di Anestesia e Rianimazione</name>
      <address>
        <city>Matera</city>
        <state>Basilicata</state>
        <zip>75100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Romito, MD</last_name>
    </contact>
    <investigator>
      <last_name>Massimo Romito, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Maurizio Bufalini, UO Anestesia Terapia Intensiva</name>
      <address>
        <city>Cesena</city>
        <state>Emilia Romagna</state>
        <zip>47023</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manlio Meca, MD</last_name>
    </contact>
    <investigator>
      <last_name>Manlio Meca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Morgagni-Pierantoni, U.O. Anestesia e Rianimazione</name>
      <address>
        <city>Forlì</city>
        <state>Emilia Romagna</state>
        <zip>47100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Terzitta, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marina Terzitta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale A. Manzoni, U.O. Anestesia e Rianimazione 1</name>
      <address>
        <city>Lecco</city>
        <state>Lombardia</state>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Nattino, MD</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppe Nattino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico San Marco, Terapia Intensiva</name>
      <address>
        <city>Zingonia (BG)</city>
        <state>Lombardia</state>
        <zip>24040</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bruno Balicco, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bruno Balicco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale SS. Antonio e Biagio e C. Arrigo, Servizio Anestesia, Rianimazione e Terapia Antalgica</name>
      <address>
        <city>Alessandria</city>
        <state>Piemonte</state>
        <zip>15100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luciana Ventura, MD</last_name>
    </contact>
    <investigator>
      <last_name>Luciana Ventura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore</name>
      <address>
        <city>Chieri</city>
        <state>Piemonte</state>
        <zip>10023</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Meinardi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stefano Meinardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Croce</name>
      <address>
        <city>Moncalieri</city>
        <state>Piemonte</state>
        <zip>10027</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilberto Fiore, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gilberto Fiore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CTO Maria Adelaide, I Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Torino</city>
        <state>Piemonte</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luisa Tedeschi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Luisa Tedeschi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Bosco, Servizio Anestesia e Rianimazione B-DEA</name>
      <address>
        <city>Torino</city>
        <state>Piemonte</state>
        <zip>10148</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Livigni, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sergio Livigni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Francesco Ferrari, Anestesia, Rianimazione e Terapia Antalgica</name>
      <address>
        <city>Casarano</city>
        <state>Puglia</state>
        <zip>73042</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giancarlo Negro, MD</last_name>
    </contact>
    <investigator>
      <last_name>Giancarlo Negro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Vittorio Emanuele, Rianimazione</name>
      <address>
        <city>Catania</city>
        <state>Sicilia</state>
        <zip>95100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giacomo Castiglione, MD</last_name>
    </contact>
    <investigator>
      <last_name>Giacomo Castiglione, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ARNAS Civico e Benfratelli, II Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Palermo</city>
        <state>Sicilia</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ettore Lo Bianco, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ettore Lo Bianco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria Annunziata, U.O Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50011</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Frigieri, MD</last_name>
    </contact>
    <investigator>
      <last_name>Francesca Frigieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria Nuova, Anestesia e Rianimazione</name>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Barattini, MD</last_name>
    </contact>
    <investigator>
      <last_name>Massimo Barattini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Careggi - Villa Monna Tessa</name>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alberto Sardu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alberto Sardu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Careggi</name>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Viaggi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bruno Viaggi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti Valdichiana Senese, U.O. di Anestesia e Rianimazione</name>
      <address>
        <city>Montepulciano</city>
        <state>Toscana</state>
        <zip>53045</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salvatore Criscuolo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Salvatore Criscuolo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale SS. Cosma e Damiano, Servizio Anestesia e Rianimazione</name>
      <address>
        <city>Pescia</city>
        <state>Toscana</state>
        <zip>51017</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentina Gori, MD</last_name>
    </contact>
    <investigator>
      <last_name>Valentina Gori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedlae di S. Chiara</name>
      <address>
        <city>Pisa</city>
        <state>Toscana</state>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Malacarne, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paolo Malacarne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Alta Val d'Elsa, Terapia Intensiva</name>
      <address>
        <city>Poggibonsi</city>
        <state>Toscana</state>
        <zip>53036</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Veneziani, MD</last_name>
    </contact>
    <investigator>
      <last_name>Andrea Veneziani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.giviti.marionegri.it</url>
    <description>GiViTI web site</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2012</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

